Bladder, cervical, lung squamous cell carcinoma, lung adenocarcinoma, head and neck, and breast cancers shared a strong bias for TCN (N = A or C or G or T) mutation signatures, as observed for the recombinant APOBEC3B protein. The gene discussed is APOBEC3B; the disease is breast cancer.